Bone Resorption, Osteoclastogenesis and Adalimumab

Trial Profile

Bone Resorption, Osteoclastogenesis and Adalimumab

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 08 Nov 2016

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Pharmacodynamics
  • Acronyms BROCAII
  • Most Recent Events

    • 27 Oct 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018.
    • 27 Oct 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
    • 24 May 2016 Planned End Date changed from 1 Sep 2015 to 1 Dec 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top